Last reviewed · How we verify

Loceryl NL — Competitive Intelligence Brief

Loceryl NL (Loceryl NL) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antifungal (morpholine derivative). Area: Dermatology.

marketed Antifungal (morpholine derivative) Fungal sterol synthesis enzymes (Δ14-reductase, Δ8-Δ7-isomerase) Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

Loceryl NL (Loceryl NL) — Galderma R&D. Loceryl is an antifungal nail lacquer that inhibits fungal cell wall synthesis by disrupting ergosterol production.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Loceryl NL TARGET Loceryl NL Galderma R&D marketed Antifungal (morpholine derivative) Fungal sterol synthesis enzymes (Δ14-reductase, Δ8-Δ7-isomerase)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antifungal (morpholine derivative) class)

  1. Galderma R&D · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Loceryl NL — Competitive Intelligence Brief. https://druglandscape.com/ci/loceryl-nl. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: